World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
8899
World Ranking
4120
National Ranking
367

Alan Winston publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Alan Winston sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 258 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Alan Winston D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Alan Winston sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 53 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Alan Winston is affiliated with Imperial College London in the United Kingdom. Their research primarily spans the field of Medicine, with a specific focus on Infectious Diseases, Emergency Medicine, Virology, Epidemiology, and Pediatrics, Perinatology and Child Health.

The scientist's main topics of work include HIV-related health complications and treatments, HIV/AIDS research and interventions, HIV research and treatment, and HIV/AIDS drug development and treatment. Additional topics explored in their publications include Pneumocystis jirovecii pneumonia detection and treatment, SARS-CoV-2 and COVID-19 research, and pharmacological effects and toxicity studies.

Alan Winston has contributed to several recent papers as an author or co-author. Notable works include:

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial (2021) published in The Lancet HIV
  • Transmission of monkeypox virus through sexual contact - A novel route of infection (2022) published in Journal of Infection
  • 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 (2020) published in HIV Medicine
  • Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial (2022) published in EClinicalMedicine
  • Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023 (2023) published in HIV Medicine

Frequent co-authors in Alan Winston's body of work include Caroline Sabin, Jaime H. Vera, Patrick Mallon, Marta Boffito, and Jasmini Alagaratnam.

The scientist has published extensively in several key academic venues. Frequent publication venues comprise HIV Medicine, AIDS, The Lancet HIV, Clinical Infectious Diseases, and EClinicalMedicine.

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012

    Ian Williams;Duncan Churchill;Jane Anderson;Marta Boffito

  • Controversies in HIV-associated neurocognitive disorders

    Sam Nightingale;Alan Winston;Scott Letendre;Benedict D Michael;Benedict D Michael

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).

    Ian Williams;Ian Williams;Duncan Churchill;Jane Anderson;Marta Boffito

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

    J Frater;K J Ewer;A Ogbe;M Pace

  • Increased brain-predicted aging in treated HIV disease

    James H. Cole;Jonathan Underwood;Matthan W.A. Caan;Davide De Francesco

  • Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

    Andrea Antinori;Gabriele Arendt;Igor Grant

  • Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

    Unknown

  • Neuroinflammation in treated HIV-positive individuals A TSPO PET study

    Jaime H. Vera;Qi Guo;James H. Cole;Adriano Boasso

  • Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.

    Lucy J Garvey;Nicola Pavese;Marios Politis;Anil Ramlackhansingh

  • Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

    Nicholas I. Paton;Ruth L. Goodall;David T. Dunn;Samuel Franzen

  • Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease

    Jonathan Underwood;Jonathan Underwood;Kevin R. Robertson;Alan Winston

  • Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.

    Wolfgang Stöhr;David Back;David Dunn;Caroline Sabin

  • Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study

    Dianne Carey;Rebekah Puls;Janaki Amin

  • 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.

    L Ryom;A Cotter;R De Miguel;C Béguelin

  • Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

    Davide De Francesco;Ferdinand W Wit;Alexander Bürkle;Sebastian Oehlke

  • Major revision version 12.0 of the European <scp>AIDS</scp> Clinical Society guidelines 2023

    Unknown

  • Cognitive impairment in people living with HIV: consensus recommendations for a new approach

    Unknown

  • Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

    L Ryom;C Boesecke;M Bracchi;J Ambrosioni

  • Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

    Alan Winston;Chris Duncombe;Patrick C. K. Li;John M. Gill

  • Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

    Unknown

  • Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

    Sophie Jose;Lisa Hamzah;Lucy J. Campbell;Teresa Hill

  • HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

    Lucy Garvey;Lucy Garvey;Alan Winston;Alan Winston;John Walsh;Frank Post

  • Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapy

    A Winston;J Amin;Pwg Mallon;Pwg Mallon;D Marriott

  • Pgp3 Antibody Enzyme-Linked Immunosorbent Assay, a Sensitive and Specific Assay for Seroepidemiological Analysis of Chlamydia trachomatis Infection

    Gillian S. Wills;Patrick J. Horner;Rosy Reynolds;Anne M. Johnson

  • Cognitive disorders in people living with HIV.

    Alan Winston;Alan Winston;Serena Spudich

  • Increasing detection of asymptomatic syphilis in HIV patients

    C E Cohen;A Winston;D Asboe;F Boag

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015

    Duncan Churchill;Laura Waters;Nadia Ahmed;Brian Angus

Frequent Co-Authors

Caroline Sabin
Caroline Sabin University College London
Frank A. Post
Frank A. Post King's College London
Marta Boffito
Marta Boffito Imperial College London
Saye Khoo
Saye Khoo University of Liverpool
Sarah Fidler
Sarah Fidler Imperial College London
Mark Nelson
Mark Nelson University of Vermont
Peter Reiss
Peter Reiss University of Amsterdam
Martin Fisher
Martin Fisher University of Sussex
David Back
David Back University of Liverpool
Clifford Leen
Clifford Leen Western General Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their scope beyond microbiology, several online health-related degrees offer flexible pathways. An online cahiim accredited health information management degree provides critical skills in data management and healthcare systems, essential for integrating microbiological data into broader health contexts.

Another option is pursuing an accelerated medical billing and coding certificate online, ideal for those seeking quick entry into the healthcare industry with roles that support clinical and laboratory services.

Many universities now offer various medical programs online, allowing students to blend microbiology expertise with broader medical knowledge, often leading to interdisciplinary career opportunities.

For a public health perspective, exploring online public health masters programs easy to get into can be beneficial. These programs enhance understanding of population health, epidemiology, and preventive medicine, complementing microbiology studies and expanding career possibilities.

Best Scientists Citing Alan Winston

Trending Scientists